Zeke Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Zeke Capital Advisors's LLY Position: Q4 2022 in Review
Zeke Capital Advisors increased its Eli Lilly (LLY) stake by 34% in Q4 2022, buying an estimated $489K and bringing the position to 5,442 shares worth $1.99M. The position accounts for 0.13% of the portfolio, ranked #74.
Zeke Capital Advisors first reported a position in LLY in Q4 2016 and has held it in 18 quarters since. The position peaked at $4.37M in Q3 2018. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Zeke Capital Advisors held 5,442 shares of Eli Lilly worth $1.99M as of Q4 2022.
- Zeke Capital Advisors bought 1,378 Eli Lilly shares in Q4 2022, an estimated $489K.
- Eli Lilly made up 0.13% of Zeke Capital Advisors's portfolio in Q4 2022, its #74 holding.
- Zeke Capital Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 18 quarters since.
- Zeke Capital Advisors's Eli Lilly position peaked at $4.37M in Q3 2018.
- 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.